ArticleFrontiers in immunology2024

Evaluating the effects of circulating inflammatory proteins as drivers and therapeutic targets for severe COVID-19.

Ancha Baranova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.